Researchers investigating the mystery of a tiny 'sin'

June 13, 2013, University of Pennsylvania
Researchers investigating the mystery of a tiny 'sin'
Black-legged ticks, which carry Lyme disease, from the Cary Institute in Millbrook, NY. Credit: Michael Benjamin

When a strain of bacteria invades a human body, the immune system responds by generating antibodies to neutralize the threat. However, during subsequent infections by a similar bacterium, the immune system has a tendency to fall back on its memory, generating the same old antibodies again, even if they're not up to the task of the fighting the new invaders.

Therein lies the crack in the body's armor against certain recurring infections, what has been called the original antigenic sin. It's a loophole in the that Dustin Brisson, assistant professor of biology in the School of Arts and Sciences at the University of Pennsylvania, suspects certain pathogens may exploit by altering their structure just enough to fool the body into making useless antibodies.

Brisson studies the of infectious diseases, in both natural and laboratory settings. He'll be able to delve deeper into microbe and human body interactions, especially the theory of original antigenic sin, now that the Burroughs Wellcome Fund has named him one of its 2013 Investigators in the Pathogenesis of Infectious Disease. The Fund supports scientists developing their early careers and helps advance basic biomedical science fields that are undervalued or in need of particular encouragement.

Brisson was awarded $500,000 of research support over five years after his nomination by Penn underwent peer review.

Most new investigators of infectious disease work in medical schools. Brisson is one of the few chosen from an arts-and-sciences department, Gregory M. Guild, biology professor and chair of the department, said.

"We hired him as a young guy right out of grad school without doing any postdoctoral studies –- a rarity these days," he said.

At Penn since 2007, Brisson teaches Introductory Biology and a seminar course, Humans in a , aimed at non-biology majors.

He would like to examine the evolution of in action against . From the bacteria's point of view, there's an ideal structure, similar enough to a previous strain to evoke the same immune response but just different enough to slip past the immune system and overwhelm the host body.

"It is unclear if any bacteria have evolved to take advantage of original antigenic sin," he said. "Hopefully, this research will illuminate the evolutionary pressures on pathogens. It's a fundamental biological and medical issue with implications for recurring and chronic ."

During a study published last year in the New England Journal of Medicine, Brisson and his colleagues learned that recurring cases of Lyme disease result from reinfection by different but related strains of the . Lyme disease is caused by the bacterium Borrelia burgdorferi, which hop aboard humans through the bite of infected black-legged ticks. Brisson has personally experienced the unpleasantness of Lyme disease, though that's not the reason he's studying it now.

"I'm interested in evolutionary biology, and Lyme disease is a very robust system to work on to answer fundamental questions in biology," he said.

If his work leads to breakthroughs in the fight against recurrent infectious disease, so much the better.

Explore further: Researchers show that in some cases, what looks like Lyme could be completely different illness transmitted by same bug

Related Stories

Researchers show that in some cases, what looks like Lyme could be completely different illness transmitted by same bug

March 4, 2013
Under the microscope, Sam Telford surveyed the tiny, spiral bacteria floating in spinal fluid taken from an 80-year-old woman. They looked very similar to the spirochete bacteria that can cause Lyme disease. But in fact, ...

Even after Lyme disease is gone, its remains may perpetuate inflammation

June 26, 2012
(Medical Xpress) -- Non-infectious proteins of the species of bacteria that causes Lyme disease can remain in the body for a long time after antibiotic therapy, and are capable of causing an inflammatory immune reaction that ...

Lyme disease bacteria take cover in lymph nodes

June 16, 2011
The bacteria that cause Lyme disease, one of the most important emerging diseases in the United States, appear to hide out in the lymph nodes, triggering a significant immune response, but one that is not strong enough to ...

Declaring a truce with our microbiological frienemies

March 27, 2013
Managing bacteria and other microorganisms in the body, rather than just fighting them, may be lead to better health and a stronger immune system, according to a Penn State biologist.

Recommended for you

Improving vaccines for the elderly by blocking inflammation

January 22, 2018
By identifying why skin immunity declines in old age, a UCL-led research team has found that an anti-inflammatory pill could help make vaccines more effective for elderly people.

Novel genomic tools provide new insight into human immune system

January 19, 2018
When the body is under attack from pathogens, the immune system marshals a diverse collection of immune cells to work together in a tightly orchestrated process and defend the host against the intruders. For many decades, ...

First vaccine developed against grass pollen allergy

January 18, 2018
Around 400 million people worldwide suffer in some form or other from a grass pollen allergy (rhinitis), with the usual symptoms of runny nose, cough and severe breathing problems. In collaboration with the Viennese firm ...

Genomics reveals key macrophages' involvement in systemic sclerosis

January 18, 2018
A new international study has made an important discovery about the key role of macrophages, a type of immune cell, in systemic sclerosis (SSc), a chronic autoimmune disease which currently has no cure.

Researchers discover key driver of atopic dermatitis

January 17, 2018
Severe eczema, also known as atopic dermatitis, is a chronic inflammatory skin condition that is driven by an allergic reaction. In their latest study, researchers at La Jolla Institute reveal an important player that promotes ...

Who might benefit from immunotherapy? New study suggests possible marker

January 16, 2018
While immunotherapy has made a big impact on cancer treatment, the fact remains that only about a quarter of patients respond to these treatments.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.